In the UK-ROI collection, individuals carrying the AGXT2-rs71615838G variant had decreased DKD risk, whereas carrying the SURF1-rs183853102A allele was associated with an increased risk of ESKD. This evidence concerns the gene AGXT2 and diabetic kidney disease.